Professor, Internal Medicine, Rush Medical College of Rush Univ
Nephrology
Roger A. Rodby is an expert in the field of Nephrology. He attended UMDNJ-Robert Wood Johnson Medical School. He received awards:"America's Top Doctors", "Chicago Magazine: Top Doctors", "Best Doctors", "Chicago Super Doctors", "Whos Who", "Top Doctors in Chicago", "Fellow (FASN)", "Consumers Guide to Top Doctors", "American Registry Top Doctors", "Americas Top Physicians", "Americas Registry of Outstanding Professionals", "Chicago Areas Top Doctors", "Fellow", "Rush University Medical Center Department of Internal Medicine Teaching Award", "The Best Doctors in America", "Medical Residents Research Paper Contest", "Highest Graduating Honors", "Phi Kappa Phi, W.I.U", "Beta Beta Beta, W.I.U", "Phi Eta Sigma, W.I.U", "Alpha Omega Alpha", "Super Doctor" and "Top MD". Roger Rodby is also a published physician. He has 64 paper published. The most recent paper is: Hemofiltration for SIRS: bloodletting, twentieth century style? Dr. Roger A. Rodby accepts Medicare payments and is registered with Medicare.gov.
Publications
- Phosphorus binding With ferric citrate is associated With fewer hospitalizations and reduced hospitalization costs.
- Ferric citrate spans mineral Metabolism and anemia domains in ESRD: a review of efficacy and safety data.
- Common clinical quandaries encountered by nephrologists: more questions answered.
- Spot PC ratio estimates of 24-hour proteinuria are more unreliable in lupus nephritis than in other forms of Chronic glomerular disease.
- Type II diabetic Nephropathy: its clinical course and therapeutic implications.
- Antihypertensive treatment in nephropathy of type II Diabetes: role of the pharmacological blockade of the renin-angiotensin system.
- An 18-year-old man With Goodpasture's syndrome and ANCA-negative central nervous system vasculitis.
- Free pentosidine and neopterin as markers of progression rate in diabetic Nephropathy. Collaborative Study Group.
- Hemofiltration for SIRS: bloodletting, twentieth century style?
- ACE inhibition in diabetic patients. Economic implications.
- The Irbesartan type II diabetic Nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group.
- Renal scanning 99mTc diethylene-triamine pentaacetic acid glomerular filtration rate (GFR) determination compared With iothalamate clearance GFR in diabetics. The Coll...
- Proteinuria, hematuria, hypertension, and decreased renal function in a patient with Diabetes for 9 years.
- Agrobacterium radiobacter peritonitis in two patients maintained on Chronic peritoneal dialysis.
- Reversal of cardiac dysfunction secondary to type 1 primary hyperoxaluria after combined liver-Kidney transplantation.
- Renal transplant arterial thrombosis: association With cyclosporine.
- Baby poop peritonitis.
- Persistence of clinical and serologic activity in patients With systemic lupus erythematosus undergoing peritoneal dialysis.
- The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients With nephropathy. The Collaborative Study Group.
- Membranoproliferative Glomerulonephritis associated with hepatitis C virus infection.
- Re-evaluation of solute transport groups using the peritoneal equilibration test.
- A clinical trial in type 2 diabetic Nephropathy.
- [Health economic consequences of the use of irbesartan in patients in Germany with type 2 Diabetes, nephropathy and hypertension].
- An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting.
- [Cost-efectiveness of Ibersartan in type II diabetic nephropathy With hypertension. A Spanish perspective].
- [Clinical and health economic implications of early treatment with irbesartan of patients with type 2 Diabetes mellitus, hypertension and nephropathy].
- Cost-effectiveness of irbesartan 300 mg given early versus late in patients with hypertension and a history of type 2 diabetes and renal Disease: a Canadian perspective.
- A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic Kidney disease.
- Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration.
- Laparoscopy in the early diagnosis and management of sclerosing encapsulating peritonitis.
- Comparison of drug dosing recommendations based on measured GFR and Kidney function estimating equations.
- Hemoglobin-AGE: a circulating marker of advanced glycosylation.
- Clinical and pathologic features of familial focal segmental glomerulosclerosis.
- Amputations associated With arteriovenous access.
- Cost-effectiveness of early irbesartan treatment versus control (standard antiHypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonis...
- Economic evaluation of the use of irbesartan and amlodipine in the treatment of diabetic nephropathy in patients With hypertension in Canada.
- Aliquot versus batch sampling methods for measurements of peritoneal dialysis adequacy in patients receiving CAPD.
- The cost-effectiveness of irbesartan in the treatment of hypertensive patients With type 2 diabetic nephropathy.
- An economic evaluation of irbesartan in the treatment of patients with type 2 Diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Neph...
- LupusQoL-US benchmarks for US patients With systemic lupus erythematosus.
- Unexpectedly severe metabolic Acidosis associated with sodium thiosulfate therapy in a patient with calcific uremic arteriolopathy.
- Can gadolinium be given safely to a patient on dialysis?
- Common clinical quandaries encountered in dialysis and ESRD: questions answered.
- Effects of High Blood Flow and High Pre-Dilution Replacement Fluid Rates on Small Solute Clearances in Hemofiltration.
- Dialytic therapies to prevent NSF following gadolinium exposure in high-risk patients.
- A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 Diabetes and hypertension in the USA.
- Accelerated venovenous hemofiltration: early technical and clinical experience.
- A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 Diabetes and hypertension.
- Preventing complications of radiographic contrast media: is there a role for dialysis?
- Gadolinium use in patients with Kidney disease: a cause for concern.
- Gadolinium-induced nephrogenic systemic fibrosis in patients with Kidney disease.
- Pharmacoeconomic challenges in the management of diabetic Nephropathy.
- Health economics studies assessing irbesartan use in patients with hypertension, type 2 Diabetes, and microalbuminuria.
- Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 Diabetes, hypertension, and microalbuminuria.
- Independent and additive impact of blood pressure control and angiotensin II receptor blockade on Renal outcomes in the irbesartan diabetic nephropathy trial: clinical...
- The use of continuous arteriovenous hemofiltration in orthotopic liver transplantation.
- The study of the effect of intensity of blood pressure management on the progression of type 1 diabetic Nephropathy: study design and baseline patient characteristics....
- Nephrotic syndrome in a patient With unilateral renal dysplasia.
- Rapid reversal of bone scan abnormalities in a patient With type 1 primary hyperoxaluria and oxalosis.
- Abnormal acyltransferase activities and accelerated cholesteryl ester transfer in patients With nephrotic syndrome.
- Blood pressures in hemodialysis and peritoneal dialysis using ambulatory blood pressure monitoring.
- Reproducibility of studies of peritoneal dialysis adequacy.
- An economic analysis of captopril in the treatment of diabetic Nephropathy. The Collaborative Study Group.
Schools
University Of Illinois College Of Medicine Chicago
UMDNJ Rutgers
Rush Presby St Lukes
Procedures Preformed
- End-Stage Renal Disease Related Services
- Hemodialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Amyloidosis
- Calcium Metabolism Disorders
- View All
Doctors Specialties
Accepted Insurances
Awards
- America's Top Doctors
- Chicago Magazine: Top Doctors
- Best Doctors
- Chicago Super Doctors
- Who’s Who
- Top Doctors in Chicago
- Fellow (FASN)
- Consumer’s Guide to Top Doctors
- American Registry Top Doctors
- America’s Top Physicians
- America’s Registry of Outstanding Professionals
- Chicago Area’s Top Doctors
- Fellow
- Rush University Medical Center Department of Internal Medicine Teaching Award
- The Best Doctors in America
- Medical Residents Research Paper Contest
- Highest Graduating Honors
- Phi Kappa Phi, W.I.U
- Beta Beta Beta, W.I.U
- Phi Eta Sigma, W.I.U
- Alpha Omega Alpha
- Super Doctor
- Top MD
Education
-
Rush University Medical Center
-
UMDNJ-Robert Wood Johnson Medical School
-
University of Illinois College of Medicine
Hospital
-
Rush University Medical Center
Drug Facts
| NPI NUMBER |
|
1043327927 |
| NPPES Provider LastName |
|
RODBY |
| NPPES Provider FirstName |
|
ROGER |
| NPPES Provider ZIPCode |
|
606071821 |
| NPPES Provider State |
|
IL |
| Specialty Description |
|
Nephrology |
| Total Claim Count |
|
564.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1043327927 |
| Last Name Of The Provider |
RODBY |
| First Name Of The Provider |
ROGER |
| View All |
|
Similar Doctors
|
Dr. Fredric L. Coe, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cosme Cruz, MD
|
|
|
Dr. Mark A. Kraus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James Paparello, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James P. Lash, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marshall D. Lindheimer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin Ling, DO
|
|
|
Dr. Shivani M. Shah, MD
|
|
|
Dr. Daiva K. Valitis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abdul M. Mohammed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Rosa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Divya Singh, MD
|
|
|
Tom Blicharski, APN
|
Doctor Directory | TOS | twitter | FB | Angel | blog